Metraipolis › archive › dc_ef574f44d93d
Methodological Assessment of High-Throughput Sequencing Platforms: Illumina vs. MGI in Clinical-Grade CFTR Genotyping — Europe PMC PMID:41373845
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41373845
- DOI
- 10.3390/ijms262311701
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T23:01:12.507Z
- SHA-256 of the archived text
d01ae313a32082f093ad1673e1f27962e586a8243423b1e6b901280230bc52eb- Stable URL of this page
https://metraipolis.com/documento/dc_ef574f44d93d
How to cite
Methodological Assessment of High-Throughput Sequencing Platforms: Illumina vs. MGI in Clinical-Grade CFTR Genotyping — Europe PMC PMID:41373845 — Europe PMC (en), https://europepmc.org/article/MED/41373845 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef574f44d93d (Metraipolis archive dc_ef574f44d93d, sha256 d01ae313a32082f093ad1673e1f27962e586a8243423b1e6b901280230bc52eb)
BibTeX
@misc{dcef574f44d93d,
title = {Methodological Assessment of High-Throughput Sequencing Platforms: Illumina vs. MGI in Clinical-Grade CFTR Genotyping — Europe PMC PMID:41373845},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41373845},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef574f44d93d; sha256 d01ae313a32082f093ad1673e1f27962e586a8243423b1e6b901280230bc52eb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41373845. Agents can read the archived copy with the MCP tool read_document.